Sparsentan Provides Better Proteinuria Reduction in FSGS ...Middle East

Medscape - News
Sparsentan Provides Better Proteinuria Reduction in FSGS
A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS. Medscape Medical News

Hence then, the article about sparsentan provides better proteinuria reduction in fsgs was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sparsentan Provides Better Proteinuria Reduction in FSGS )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News